Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45 years in the United States

JF Laprise, HW Chesson, LE Markowitz… - Annals of internal …, 2020 - acpjournals.org
Effectiveness and Cost-Effectiveness of HPV Vaccination Through Age 45 In the United States,
the vaccine against human papillomavirus … article estimates the cost-effectiveness of the …

Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review

RA Mahumud, K Alam, SA Keramat, GM Ormsby… - PloS one, 2020 - journals.plos.org
cost-effectiveness, ten studies concluded that 9vHPV vaccination was cost-effective and
two … The addition of adolescent boys into immunisation programs was cost effective when …

Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis

JJ Kim, KT Simms, J Killen, MA Smith, EA Burger… - PLoS …, 2021 - journals.plos.org
… A nonavalent human papillomavirus (HPV) vaccine has been licensed for use in women
and men up to age 45 years in the United States. The cost-effectiveness of HPV vaccination for …

Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend

F Gervais, K Dunton, Y Jiang, N Largeron - BMC Public Health, 2017 - Springer
… the cost-effectiveness profile of different HPV prevention strategies and, in particular,
those combining vaccination with changes in screening practices; (2) explore the cost-effectiveness

Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a …

KT Simms, JF Laprise, MA Smith, JB Lew… - The Lancet Public …, 2016 - thelancet.com
cost-effectiveness studies have evaluated the optimum pricing of the human papillomavirus
(… , and have shown that a key driver of cost-effectiveness is the reduction in screen-detected …

Cost-effectiveness of human papillomavirus vaccination in Germany

O Damm, J Horn, RT Mikolajczyk… - Cost Effectiveness and …, 2017 - Springer
… The aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV)
vaccination in addition to the current cervical cancer screening programme in Germany using …

[HTML][HTML] The cost-effectiveness of human papillomavirus vaccination in the Philippines

CL Llave, MEV Uy, HY Lam, JG Aldaba, CC Yacapin… - Vaccine, 2022 - Elsevier
cost-effectiveness of HPV vaccination in the Philippines have shown that HPV vaccination is
cost-effective, … The purpose of this study is to estimate the cost-effectiveness of different HPV …

Human papillomavirus vaccination at the national and provincial levels in China: a cost-effectiveness analysis using the PRIME model

L Zhou, B Gu, J Wang, G Liu, X Zhang - BMC Public Health, 2022 - Springer
… This study aimed to assess the cost-effectiveness of incorporating different HPV vaccines …
Cost effect is the ratio of the increased cost of saving a unit DALY (cost-effectiveness ratio, CER…

Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination

SS Ng, R Hutubessy, N Chaiyakunapruk - Vaccine, 2018 - Elsevier
… The success of human papillomavirus (HPV) national immunization program depends on
effective strategies in optimizing the uptake of HPV vaccine. Given the increasing number of …

[HTML][HTML] Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands

JJM Simons, N Vida, TA Westra, MJ Postma - Vaccine, 2020 - Elsevier
… against human papillomavirus (HPV) infection is a highly effective and cost-effective intervention
to … Here we assessed the benefits and cost-effectiveness of gender-neutral vaccination. …